AAAAAA
Results:
1-7
|
Results: 7
Authors:
WOLTERS EC
JANSEN ENH
TUYNMANQUA HG
BERGMANS PLM
Citation: Ec. Wolters et al., OLANZAPINE IN THE TREATMENT OF DOPAMINOMIMETIC PSYCHOSIS IN PATIENTS WITH PARKINSONS-DISEASE - REPLY FROM THE AUTHORS, Neurology, 50(4), 1998, pp. 1196-1196
Authors:
WOLTERS EC
JANSEN ENH
TUYNMANQUA HG
BERGMANS PLM
Citation: Ec. Wolters et al., OLANZAPINE IN THE TREATMENT OF DOPAMINOMIMETIC PSYCHOSIS IN PATIENTS WITH PARKINSONS-DISEASE, Neurology, 47(4), 1996, pp. 1085-1087
Authors:
WOLTERS EC
TISSINGH G
BERGMANS PLM
KUIPER MA
Citation: Ec. Wolters et al., DOPAMINE AGONISTS IN PARKINSONS-DISEASE, Neurology, 45(3), 1995, pp. 28-34
Authors:
KUIPER MA
VISSER JJ
BERGMANS PLM
SCHELTENS P
WOLTERS EC
Citation: Ma. Kuiper et al., DECREASED CEREBROSPINAL-FLUID NITRATE LEVELS IN PARKINSONS-DISEASE, ALZHEIMERS-DISEASE AND MULTIPLE SYSTEM ATROPHY PATIENTS, Journal of the neurological sciences, 121(1), 1994, pp. 46-49
Authors:
KONINGS CH
KUIPER MA
BERGMANS PLM
GRIJPMA AM
VANKAMP GJ
WOLTERS EC
Citation: Ch. Konings et al., INCREASED ANGIOTENSIN-CONVERTING ENZYME-ACTIVITY IN CEREBROSPINAL-FLUID OF TREATED PATIENTS WITH PARKINSONS-DISEASE, Clinica chimica acta, 231(1), 1994, pp. 101-106
Authors:
KUIPER MA
VANKAMP GJ
BERGMANS PLM
SCHELTENS P
WOLTERS EC
Citation: Ma. Kuiper et al., SERUM ALPHA-1-ANTICHYMOTRYPSIN IS NOT A USEFUL MARKER FOR ALZHEIMERS-DISEASE OR DEMENTIA IN PARKINSONS-DISEASE, Journal of neural transmission. Parkinson's disease and dementia section, 6(2), 1993, pp. 145-149
Authors:
KUIPER MA
KONINGS CH
BERGMANS PLM
WOLTERS EC
Citation: Ma. Kuiper et al., WHOLE-BLOOD MONOAMINE-OXIDASE ACTIVITY IN PARKINSONS-DISEASE AND MULTIPLE SYSTEM ATROPHY PATIENTS, Journal of the neurological sciences, 117(1-2), 1993, pp. 41-45
Risultati:
1-7
|